Alexandra L Gerber
Overview
Explore the profile of Alexandra L Gerber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramundo M, da Fonseca G, Ten-Caten F, Gerber A, Guimaraes A, Manuli E, et al.
Sci Rep
. 2025 Feb;
15(1):6745.
PMID: 40000671
Chikungunya virus (CHIKV) infection often results in a chronic joint condition known as Post-Chikungunya Chronic Inflammatory Joint Disease (pCHIKV-CIJD). This condition disrupts individuals' daily lives and contributes to increased healthcare...
2.
Fam B, Cadore N, Sbruzzi R, Feira M, Giudicelli G, de Almeida L, et al.
Front Immunol
. 2025 Jan;
15:1444620.
PMID: 39744633
Introduction: The COVID-19 pandemic had a widespread global impact and presented numerous challenges. The emergence of SARS-CoV-2 variants has changed transmission rates and immune evasion, possibly impacting the severity. This...
3.
Lamarca A, Souza U, Moreira F, de Almeida L, de Menezes M, de Souza A, et al.
Viruses
. 2023 Apr;
15(4).
PMID: 37112869
Brazil currently ranks second in absolute deaths by COVID-19, even though most of its population has completed the vaccination protocol. With the introduction of Omicron in late 2021, the number...
4.
Dos Santos Lazari C, Ramundo M, Ten-Caten F, Bressan C, de Filippis A, Manuli E, et al.
PLoS Negl Trop Dis
. 2023 Jan;
17(1):e0011037.
PMID: 36608155
Background: Chikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25-40% individuals and, though most of...
5.
Lamarca A, de Almeida L, Francisco R, Cavalcante L, Brustolini O, Gerber A, et al.
Microb Genom
. 2022 Sep;
8(9).
PMID: 36106981
During the first semester of 2021, all of Brazil has suffered an intense wave of COVID-19 associated with the Gamma variant. In July, the first cases of Delta variant were...
6.
da Silva Francisco Junior R, de Almeida L, Lamarca A, Cavalcante L, Martins Y, Gerber A, et al.
Front Public Health
. 2022 Mar;
10:849978.
PMID: 35273945
In this study, we report the first case of intra-host SARS-CoV-2 recombination during a coinfection by the variants of concern (VOC) AY.33 (Delta) and P.1 (Gamma) supported by sequencing reads...
7.
Lamarca A, de Almeida L, da Silva Francisco Jr R, Cavalcante L, Machado D, Brustolini O, et al.
J Virol
. 2021 Nov;
96(2):e0122821.
PMID: 34730387
No abstract available.
8.
da Silva Francisco Junior R, Lamarca A, de Almeida L, Cavalcante L, Machado D, Martins Y, et al.
Viruses
. 2021 Oct;
13(10).
PMID: 34696443
In the present study, we provide a retrospective genomic epidemiology analysis of the SARS-CoV-2 pandemic in the state of Rio de Janeiro, Brazil. We gathered publicly available data from GISAID...
9.
Lamarca A, de Almeida L, da Silva Francisco Jr R, Fassarella Agnez Lima L, Scortecci K, Perez V, et al.
PLoS Negl Trop Dis
. 2021 Oct;
15(10):e0009835.
PMID: 34644287
The sharp increase of COVID-19 cases in late 2020 has made Brazil the new epicenter of the ongoing SARS-CoV-2 pandemic. The novel viral lineages P.1 (Variant of Concern Gamma) and...
10.
Voloch C, da Silva Francisco Jr R, de Almeida L, Brustolini O, Cardoso C, Gerber A, et al.
Virus Evol
. 2021 Oct;
7(2):veab078.
PMID: 34642605
Long-term infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a challenge to virus dispersion and the control of coronavirus disease 2019 (COVID-19) pandemic. The reason why some people...